|
시장보고서
상품코드
1983141
CRO(의약품 임상시험수탁기관) 시장 : 서비스 유형별, 최종사용자별, 단계별, 아웃소싱 유형별, 치료 분야별, 임상시험 유형별, 활용 기술별, 지역별Contract Research Organization Market, By Service Type, By End User, By Phase, By Type of Outsourcing, By Therapeutic Area, By Clinical Trial Type, By Technology Utilized, By Geography |
||||||
CRO(의약품 임상시험수탁기관) 시장은 2026년에 913억 9,000만 달러로 추정되며, 2033년까지 1,758억 4,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 9.8%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 913억 9,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 9.80% | 2033년 시장 규모 예측: | 1,758억 4,000만 달러 |
세계 CRO 시장은 제약 및 생명공학 산업에서 매우 중요한 부분을 차지하고 있으며, 제약회사, 생명공학 기업, 의료기기 제조업체 및 학술 기관을 대신하여 임상시험, 의약품 규제 대응, 데이터 관리 및 다양한 연구 활동을 수행하는 전문 서비스 제공업체로서 역할을 하고 있습니다. 역할을 수행하고 있습니다.
이들 기관은 단순한 데이터 수집 기관에서 전임상시험부터 시판 후 조사까지 의약품 개발 라이프사이클 전반에 걸쳐 엔드투엔드 솔루션을 제공하는 종합적인 연구 파트너로 발전해 왔습니다. CRO 시장은 임상시험의 복잡성 증가, 의약품 개발 비용 상승, 엄격한 규제 요건, 혁신과 핵심 역량에 집중하기 위해 비핵심 업무를 아웃소싱하는 제약 업계의 전략적 전환에 힘입어 전례 없는 성장세를 보이고 있습니다.
이 시장은 임상 연구 서비스, 검사 서비스, 컨설팅 서비스, 데이터 관리 서비스 등 다양한 서비스 카테고리를 포괄하고 있으며, 각 서비스 카테고리는 신약 개발 및 개발 프로세스 가속화에 매우 중요한 역할을 하고 있습니다. 임상시험의 세계 특성 및 지역별로 상이한 규제 준수에 대한 전문적 지식이 요구되는 상황에서 CRO는 최고 수준의 품질과 규제 준수를 유지하면서 새로운 치료 솔루션을 효율적이고 비용 효율적으로 시장에 출시하는 데 있어 필수적인 파트너로 자리매김하고 있습니다. 필수적인 파트너로 자리매김하고 있습니다.
시장 역학
세계 CRO 시장은 제약 연구 환경을 계속 변화시키고 있는 몇 가지 강력한 촉진요인에 의해 주도되고 있습니다. 그 주요 요인은 의약품 개발 프로세스의 높은 비용과 복잡성 증가로 인해 제약기업들은 비용 효율적인 솔루션과 전문성을 제공하는 전문 CRO에 임상시험 업무를 위탁하는 추세입니다. 만성질환의 증가, 세계 인구의 고령화, 혁신적인 치료 솔루션에 대한 긴급한 요구로 인해 임상 연구 서비스에 대한 수요가 증가하고 있습니다. 한편, 자체 연구 역량이 부족한 중소규모의 바이오기업이 증가함에 따라 CRO의 잠재적 시장은 더욱 확대되고 있습니다.
그러나 이 시장은 지역마다 다른 엄격한 규제 프레임워크 등 심각한 제약에 직면해 있습니다. 이로 인해 국제적으로 사업을 전개하는 CRO에게는 컴플라이언스 이슈와 업무의 복잡성이 발생하고 있습니다. 또한, 아웃소싱 업무의 데이터 보안, 지적재산권 보호, 품질 관리에 대한 우려도 시장 확대의 걸림돌로 작용하고 있습니다.
또한, 숙련된 임상연구 전문가 부족과 전 세계 운영 인프라 구축에 따른 높은 비용은 진입과 성장에 큰 장벽이 되고 있습니다. 이러한 도전에도 불구하고, 시장에는 큰 기회가 존재합니다. 그 원동력은 업무 효율성을 높이고 임상시험 기간을 단축하는 인공지능, 머신러닝, 전자 데이터 수집 시스템 등 디지털 기술의 급속한 보급입니다. 또한, 맞춤형 의료, 유전자 치료, 바이오의약품의 부상은 전문 CRO 서비스에 새로운 길을 열어주고 있습니다.
리얼월드 데이터(REW) 생성, 분산형 임상시험, 환자 중심 임상시험 설계에 대한 관심이 높아지고 있는 것도 성장의 기회가 되고 있습니다. 또한, 신흥시장에서의 임상연구 활동의 확대도 마찬가지이며, CRO는 이를 통해 비용적 우위와 다양한 환자군에 대한 접근성을 활용할 수 있습니다.
본 조사의 주요 특징
- 세계의 CRO 시장에 대한 상세한 분석을 제공하며, 2025년을 기준 연도, 예측 기간(2026-2033년)의 시장 규모(10억 달러) 및 CAGR(%)을 제시하는 보고서입니다.
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 회사 개요, 제품 포트폴리오, 주요 특징, 재무 성과 및 전략과 같은 매개 변수를 기반으로 세계 CRO 시장의 주요 기업 프로파일을 프로파일링합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 CRO 시장을 분석하기 위해 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 CRO 시장 : 서비스 유형별, 2021-2033년
제5장 세계의 CRO 시장 : 최종사용자별, 2021-2033년
제6장 세계의 CRO 시장 : 단계별, 2021-2033년
제7장 세계의 CRO 시장 : 아웃소싱 유형별, 2021-2033년
제8장 세계의 CRO 시장 : 치료 분야별, 2021-2033년
제9장 세계의 CRO 시장 : 임상시험 유형별, 2021-2033년
제10장 세계의 CRO 시장 : 활용 기술별, 2021-2033년
제11장 세계의 CRO 시장 : 지역별, 2021-2033년
제12장 경쟁 구도
제13장 애널리스트의 추천
제14장 참고문헌 및 조사 방법
KSM 26.04.15Contract Research Organization Market is estimated to be valued at USD 91.39 Bn in 2026 and is expected to reach USD 175.84 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 91.39 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.80% | 2033 Value Projection: | USD 175.84 Bn |
The global contract research organization market represents a pivotal segment within the pharmaceutical and biotechnology ecosystem, serving as specialized service providers that conduct clinical trials, regulatory affairs, data management, and various research activities on behalf of pharmaceutical companies, biotechnology firms, medical device manufacturers, and academic institutions.
These organizations have evolved from simple data collection entities to comprehensive research partners offering end-to-end solutions acAoss the entire drug development lifecycle, from preclinical studies to post-market surveillance. The contract research organization market has experienced unprecedented growth driven by the increasing complexity of clinical trials, rising drug development costs, stringent regulatory requirements, and the pharmaceutical industry's strategic shift toward outsourcing non-core activities to focus on innovation and core competencies.
This market encompasses various service categories including clinical research services, laboratory services, consulting services, and data management services, each playing a crucial role in accelerating drug discovery and development processes. The global nature of clinical trials, coupled with the need for specialized expertise in regulatory compliance across different geographical regions, has positioned contract research organization as indispensable partners in bringing new therapeutic solutions to market efficiently and cost-effectively while maintaining the highest standards of quality and regulatory compliance.
Market Dynamics
The global contract research organizations market is propelled by several compelling drivers that continue to reshape the pharmaceutical research landscape, with the primary catalyst being the escalating costs and complexity of drug development processes, which have incentivized pharmaceutical companies to outsource clinical trial operations to specialized CROs that offer cost-effective solutions and expertise. The increasing prevalence of chronic diseases, aging global population, and the urgent need for innovative therapeutic solutions have amplified the demand for clinical research services, while the growing number of small and mid-sized biotechnology companies lacking in-house research capabilities has further expanded the addressable market for contract research organizations.
However, the market faces significant restraints including stringent regulatory frameworks that vary across different geographical regions, creating compliance challenges and operational complexities for contract research organizations operating internationally, while concerns regarding data security, intellectual property protection, and quality control in outsourced operations continue to pose challenges for market expansion.
Additionally, the shortage of skilled clinical research professionals and the high costs associated with establishing global operational infrastructure represent substantial barriers to entry and growth. Despite these challenges, the market presents tremendous opportunities driven by the rapid adoption of digital technologies such as artificial intelligence, machine learning, and electronic data capture systems that enhance operational efficiency and reduce trial timelines, while the emergence of personalized medicine, gene therapy, and biologics creates new avenues for specialized contract research organizations services.
The increasing focus on real-world evidence generation, decentralized clinical trials, and patient-centric trial designs offers additional growth opportunities, as does the expanding clinical research activities in emerging markets where CROs can leverage cost advantages and access to diverse patient populations.
Key Features of the Study
- This report provides in-depth analysis of the global contract research organizations market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global contract research organizations market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include IQVIA Holdings Inc, Labcorp Drug Development (Covance), Parexel International, Syneos Health, ICON plc, Thermo Fisher Scientific (PPD Division), WuXi AppTec, Charles River Laboratories, Medpace Holdings, Fortrea, Novotech, Ergomed Group, PSI CRO, KCR, and Clinipace
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global contract research organizations market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract research organizations market
Market Segmentation
- Service Type Insights (Revenue, USD Bn, 2021 - 2033)
- Clinical Research Services
- Preclinical Research Services
- Laboratory Services
- Other Services
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Manufacturers
- Academic and Research Institutions
- Government Organizations
- Others (e.g., CROs supporting non-pharma sectors)
- Phase Insights (Revenue, USD Bn, 2021 - 2033)
- Phase I
- Phase II
- Phase III
- Phase IV
- Type of Outsourcing Insights (Revenue, USD Bn, 2021 - 2033)
- Full-Service Outsourcing
- Functional Service Provider (FSP) Outsourcing
- Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Cardiovascular
- Neurology
- Infectious Diseases
- Immunology
- Others (e.g., endocrinology, respiratory)
- Clinical Trial Type Insights (Revenue, USD Bn, 2021 - 2033)
- Interventional Trials
- Observational Trials
- Expanded Access Trials
- Technology Utilized Insights (Revenue, USD Bn, 2021 - 2033)
- Traditional Methods
- Digital Health Platforms
- AI & Machine Learning Applications
- Blockchain & Data Security Technologies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- IQVIA Holdings Inc
- Labcorp Drug Development (Covance)
- Parexel International
- Syneos Health
- ICON plc
- Thermo Fisher Scientific (PPD Division)
- WuXi AppTec
- Charles River Laboratories
- Medpace Holdings
- Fortrea
- Novotech
- Ergomed Group
- PSI CRO
- KCR
- Clinipace
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Contract Research Organization Market, By Service Type
- Global Contract Research Organization Market, By End User
- Global Contract Research Organization Market, By Phase
- Global Contract Research Organization Market, By Type of Outsourcing
- Global Contract Research Organization Market, By Therapeutic Area
- Global Contract Research Organization Market, By Clinical Trial Type
- Global Contract Research Organization Market, By Technology Utilized
- Global Contract Research Organization Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Contract Research Organization Market, By Service Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clinical Research Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Preclinical Research Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Laboratory Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Other Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Contract Research Organization Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Medical Device Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Government Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (e.g., CROs supporting non-pharma sectors)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Contract Research Organization Market, By Phase, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Phase I
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Phase II
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Phase III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Phase IV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Contract Research Organization Market, By Type of Outsourcing, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Full-Service Outsourcing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Functional Service Provider (FSP) Outsourcing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Contract Research Organization Market, By Therapeutic Area, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (e.g., endocrinology, respiratory)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Contract Research Organization Market, By Clinical Trial Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Interventional Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Observational Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Expanded Access Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Contract Research Organization Market, By Technology Utilized, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Traditional Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Digital Health Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- AI & Machine Learning Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Blockchain & Data Security Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
11. Global Contract Research Organization Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Outsourcing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Utilized, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Outsourcing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Utilized, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Outsourcing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Utilized, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Outsourcing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Utilized, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Outsourcing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Utilized, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Phase, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type of Outsourcing, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology Utilized, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- IQVIA Holdings Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Labcorp Drug Development (Covance)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific (PPD Division)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medpace Holdings
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fortrea
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ergomed Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PSI CRO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Clinipace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
